Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH and IGF-I in Adult GHD with Diabetes
NCT01020955Phase 3Completed
- Sponsor
- Karolinska University Hospital
- Start
- Oct 2009
- Primary completion
- Nov 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of mecasermin in growth hormone deficiency (GHD), type 2 diabetes mellitus (T2DM), sponsored by Karolinska University Hospital. Started Oct 2009; status: completed.
02
Drugs
mecasermin
03
Conditions
growth hormone deficiency (GHD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01020955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01020955.